JP2017517261A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017517261A5 JP2017517261A5 JP2016569420A JP2016569420A JP2017517261A5 JP 2017517261 A5 JP2017517261 A5 JP 2017517261A5 JP 2016569420 A JP2016569420 A JP 2016569420A JP 2016569420 A JP2016569420 A JP 2016569420A JP 2017517261 A5 JP2017517261 A5 JP 2017517261A5
- Authority
- JP
- Japan
- Prior art keywords
- deoxyuridine
- aptamer
- protein
- seq
- methyluridine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462005300P | 2014-05-30 | 2014-05-30 | |
| US62/005,300 | 2014-05-30 | ||
| PCT/US2015/033355 WO2015184372A1 (en) | 2014-05-30 | 2015-05-29 | Nucleic acid compounds for binding to complement component 3 protein |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017517261A JP2017517261A (ja) | 2017-06-29 |
| JP2017517261A5 true JP2017517261A5 (enExample) | 2019-03-14 |
| JP6824041B2 JP6824041B2 (ja) | 2021-02-03 |
Family
ID=53398218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016569420A Expired - Fee Related JP6824041B2 (ja) | 2014-05-30 | 2015-05-29 | ３つのタンパク質を補体成分に結合するための核酸化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11466275B2 (enExample) |
| EP (1) | EP3149173B1 (enExample) |
| JP (1) | JP6824041B2 (enExample) |
| CN (2) | CN106459979B (enExample) |
| CA (1) | CA2949246C (enExample) |
| ES (1) | ES2664179T3 (enExample) |
| NO (1) | NO2718257T3 (enExample) |
| WO (1) | WO2015184372A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10927380B2 (en) * | 2016-07-01 | 2021-02-23 | Somalogic, Inc. | Oligonucleotides comprising modified nucleosides |
| US12202848B2 (en) * | 2019-10-18 | 2025-01-21 | Fujifilm Wako Pure Chemical Corporation | Phosphoramidite activator |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395888B1 (en) | 1996-02-01 | 2002-05-28 | Gilead Sciences, Inc. | High affinity nucleic acid ligands of complement system proteins |
| US6140490A (en) * | 1996-02-01 | 2000-10-31 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands of complement system proteins |
| WO1997042317A1 (en) * | 1996-05-07 | 1997-11-13 | T Cell Sciences, Inc. | APTAMERS FOR COMPLEMENT PROTEIN C3b |
| US20020082227A1 (en) * | 1999-09-30 | 2002-06-27 | Scott Henry | Use of oligonucleotides for inhibition of complement activation |
| US20030219801A1 (en) * | 2002-03-06 | 2003-11-27 | Affymetrix, Inc. | Aptamer base technique for ligand identification |
| HUE025489T2 (en) * | 2006-01-17 | 2016-04-28 | Somalogic Inc | Multiplexed analysis of test samples |
| US7947447B2 (en) * | 2007-01-16 | 2011-05-24 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
| US8975026B2 (en) * | 2007-01-16 | 2015-03-10 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
| US8927509B2 (en) * | 2008-05-20 | 2015-01-06 | The Research Foundation Of State University Of New York | Aptamer modulators of complement protein C3 and biologically active proteolytic products thereof |
| NZ602618A (en) * | 2010-04-12 | 2013-12-20 | Somalogic Inc | Aptamers to beta-ngf and their use in treating beta-ngf mediated diseases and disorders |
| WO2012122540A1 (en) * | 2011-03-10 | 2012-09-13 | Somalogic, Inc. | Aptamers for clostridium difficile diagnostics |
| AU2013243574B2 (en) | 2012-04-03 | 2017-12-07 | Novelmed Therapeutics, Inc | Humanized and chimeric anti-factor C3 antibodies and uses thereof |
| IL264792B2 (en) * | 2016-08-24 | 2023-10-01 | Sangamo Therapeutics Inc | Engineered target-specific zinc-finger nucleases |
| US12441789B2 (en) * | 2019-07-11 | 2025-10-14 | Memorial Sloan Kettering Cancer Center | DLL3-targeting antibodies and uses thereof |
-
2012
- 2012-06-08 NO NO12796164A patent/NO2718257T3/no unknown
-
2015
- 2015-05-29 CA CA2949246A patent/CA2949246C/en active Active
- 2015-05-29 ES ES15729302.8T patent/ES2664179T3/es active Active
- 2015-05-29 CN CN201580028344.6A patent/CN106459979B/zh not_active Expired - Fee Related
- 2015-05-29 JP JP2016569420A patent/JP6824041B2/ja not_active Expired - Fee Related
- 2015-05-29 WO PCT/US2015/033355 patent/WO2015184372A1/en not_active Ceased
- 2015-05-29 US US15/311,714 patent/US11466275B2/en active Active
- 2015-05-29 EP EP15729302.8A patent/EP3149173B1/en not_active Not-in-force
- 2015-05-29 CN CN201910922493.7A patent/CN110643610A/zh active Pending
-
2022
- 2022-08-29 US US17/822,854 patent/US20230093170A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kohlberger et al. | SELEX: Critical factors and optimization strategies for successful aptamer selection | |
| Marušič et al. | G-rich VEGF aptamer with locked and unlocked nucleic acid modifications exhibits a unique G-quadruplex fold | |
| Tichon et al. | A conserved abundant cytoplasmic long noncoding RNA modulates repression by Pumilio proteins in human cells | |
| Morris et al. | High affinity ligands from in vitro selection: complex targets | |
| KR20230028375A (ko) | 원형 rna 번역을 구동하는 유전 요소와 이를 사용하는 방법 | |
| EP3049523B1 (en) | Multiaptamer target detection | |
| Thakur et al. | Regulation of BRCA1 transcription by specific single-stranded DNA binding factors | |
| Zimmermann et al. | Genomic SELEX: a discovery tool for genomic aptamers | |
| US20130116129A1 (en) | Method for detecting target molecules | |
| Joeng et al. | ssDNA aptamers that recognize diclofenac and 2-anilinophenylacetic acid | |
| JP2021520221A (ja) | 新規小分子活性化ｒｎａ | |
| Oo et al. | Long non-coding RNAs direct the SWI/SNF complex to cell type-specific enhancers | |
| JP2019527043A (ja) | 修飾ヌクレオシドを含むオリゴヌクレオチド | |
| Liu et al. | NAP-seq reveals multiple classes of structured noncoding RNAs with regulatory functions | |
| JP7465507B2 (ja) | Ｓｔａｐｌｅ核酸を利用したタンパク質翻訳反応の抑制法 | |
| Kotkowiak et al. | Novel isoguanine derivative of unlocked nucleic acid—Investigations of thermodynamics and biological potential of modified thrombin binding aptamer | |
| JP6706417B2 (ja) | アプタマーの製造方法 | |
| CN103898119B (zh) | 一种多西紫杉醇的核酸适配体、核酸适配体衍生物及其用途 | |
| Liew et al. | A novel L-RNA aptamer to regulate the pUG fold RNA-induced gene expression in vivo | |
| US20200157537A1 (en) | Modulating RNA Interactions with Polycomb Repressive Complex 1 (PRC1) | |
| JP7776924B2 (ja) | 変異ＦＵＳの発現を選択的に抑制する修飾ｓｉＲＮＡ | |
| TWI695068B (zh) | 用於結合生長分化因子１１的核酸化合物 | |
| Ducongé | Improvement of aptamers by high-throughput sequencing of doped-SELEX | |
| Dausse et al. | In vitro selection procedures for identifying DNA and RNA aptamers targeted to nucleic acids and proteins | |
| Martin et al. | Characterization of the murine C3a receptor enhancer-promoter: expression control by an activator protein 1 sequence and an Ets-like site |